Miami Cancer Institute

Miami Cancer Institute to Present Advances in Breast Cancer Research at 2023 San Antonio Breast Cancer Symposium

November 17, 2023

Dr. Mahtani smiling in a hospitalMIAMI, FL & SAN ANTONIO, TX – November 17, 2023 – Miami Cancer Institute, part of Baptist Health South Florida, today announced that its researchers will present several posters at this year’s San Antonio Breast Cancer Symposium (SABCS), hosted December 5-9 at the Henry B. Gonzalez Convention Center. The presentations will highlight research into breast cancer in special populations, new approaches to metastatic disease, and studies of other novel treatment regimens for breast cancer patients.

“The San Antonio Breast Cancer Symposium is one of the most important annual meetings for breast oncologists. I am pleased with the quality and promise of our presentations at this year’s symposium,” said Reshma L. Mahtani, DO, chief of breast medical oncology at Miami Cancer Institute. “My colleagues and I will share exciting findings in San Antonio, including studies that evaluated the benefit of breast cancer treatments in geriatric patients and a quality improvement initiative geared towards individualizing management strategies for HER2+ metastatic breast cancer, among others.”

Miami Cancer Institute researchers led the following research to be presented at SABCS 2023:

 

 

 

Poster Presentations

Wednesday, December 6, 2023

Correlative analysis of Breast Cancer Index with CTS5 for prediction of extended endocrine benefit in the BCI Registry study

Presenter: Naomi Dempsey, M.D.

Time: 12:00 p.m. – 2:00 p.m. CT

Location: Halls 2-3

Number: PO1-02-03

 

Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)

Co-First Author: Reshma L. Mahtani, D.O.*

Time: 5:30 p.m. – 6:30 p.m. CT

Location: Hemisfair Ballroom 1-2

Number: PS 08-04

*Dr. Mahtani is the co-first author of this research, not the presenter.

 

Thursday, December 7, 2023

Empowering Oncologists to Develop Individualized Management Strategies for HER2+ Metastatic Breast Cancer: Findings from a Quality Improvement Initiative

Presenter: Reshma L. Mahtani, D.O.

Time: 5:00 p.m. – 7:00 p.m. CT

Location: Halls 2-3

Number: PO4-04-03

 

Chemotherapy in geriatric patients with early stage HER2+ breast cancer: A National Cancer Database analysis

Presenter: Reshma L. Mahtani, D.O.

Time: 5:30 p.m. – 6:30 p.m.

Location: Stars at Night Ballroom 3-4

Number: PS 13-08

 

Systemic therapy in geriatric patients with triple negative breast cancer: a National Cancer Database analysis

Presenter: Ana Sandoval-Leon, M.D.

Time: 5:30 p.m. – 6:30 p.m. CT

Location: Stars at Night Ballroom 3-4

Number: PS 13-07

 

For updates from the San Antonio Breast Cancer Symposium 2023, look for #SABCS2023 on social media and follow Miami Cancer Institute on Twitter (X) at @MiamiCancerInst.

 

About Miami Cancer Institute

Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK. For more information, please visit https://cancer.baptisthealth.net/miami-cancer-institute.

Miami Cancer Institute is part of Baptist Health Cancer Care, the largest cancer program in South Florida, with locations from the Florida Keys to the Palm Beaches.

###

 


Language Preference / Preferencia de idioma

I want to see the site in English

Continue In English

Quiero ver el sitio en Español

Continuar en español